Cargando…
High-throughput proteomics: a methodological mini-review
Proteomics plays a vital role in biomedical research in the post-genomic era. With the technological revolution and emerging computational and statistic models, proteomic methodology has evolved rapidly in the past decade and shed light on solving complicated biomedical problems. Here, we summarize...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362039/ https://www.ncbi.nlm.nih.gov/pubmed/35922478 http://dx.doi.org/10.1038/s41374-022-00830-7 |
_version_ | 1784764644235149312 |
---|---|
author | Cui, Miao Cheng, Chao Zhang, Lanjing |
author_facet | Cui, Miao Cheng, Chao Zhang, Lanjing |
author_sort | Cui, Miao |
collection | PubMed |
description | Proteomics plays a vital role in biomedical research in the post-genomic era. With the technological revolution and emerging computational and statistic models, proteomic methodology has evolved rapidly in the past decade and shed light on solving complicated biomedical problems. Here, we summarize scientific research and clinical practice of existing and emerging high-throughput proteomics approaches, including mass spectrometry, protein pathway array, next-generation tissue microarrays, single-cell proteomics, single-molecule proteomics, Luminex, Simoa and Olink Proteomics. We also discuss important computational methods and statistical algorithms that can maximize the mining of proteomic data with clinical and/or other ‘omics data. Various principles and precautions are provided for better utilization of these tools. In summary, the advances in high-throughput proteomics will not only help better understand the molecular mechanisms of pathogenesis, but also to identify the signature signaling networks of specific diseases. Thus, modern proteomics have a range of potential applications in basic research, prognostic oncology, precision medicine, and drug discovery. |
format | Online Article Text |
id | pubmed-9362039 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93620392022-08-10 High-throughput proteomics: a methodological mini-review Cui, Miao Cheng, Chao Zhang, Lanjing Lab Invest Review Article Proteomics plays a vital role in biomedical research in the post-genomic era. With the technological revolution and emerging computational and statistic models, proteomic methodology has evolved rapidly in the past decade and shed light on solving complicated biomedical problems. Here, we summarize scientific research and clinical practice of existing and emerging high-throughput proteomics approaches, including mass spectrometry, protein pathway array, next-generation tissue microarrays, single-cell proteomics, single-molecule proteomics, Luminex, Simoa and Olink Proteomics. We also discuss important computational methods and statistical algorithms that can maximize the mining of proteomic data with clinical and/or other ‘omics data. Various principles and precautions are provided for better utilization of these tools. In summary, the advances in high-throughput proteomics will not only help better understand the molecular mechanisms of pathogenesis, but also to identify the signature signaling networks of specific diseases. Thus, modern proteomics have a range of potential applications in basic research, prognostic oncology, precision medicine, and drug discovery. Nature Publishing Group US 2022-08-03 2022 /pmc/articles/PMC9362039/ /pubmed/35922478 http://dx.doi.org/10.1038/s41374-022-00830-7 Text en © The Author(s), under exclusive licence to United States and Canadian Academy of Pathology 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Cui, Miao Cheng, Chao Zhang, Lanjing High-throughput proteomics: a methodological mini-review |
title | High-throughput proteomics: a methodological mini-review |
title_full | High-throughput proteomics: a methodological mini-review |
title_fullStr | High-throughput proteomics: a methodological mini-review |
title_full_unstemmed | High-throughput proteomics: a methodological mini-review |
title_short | High-throughput proteomics: a methodological mini-review |
title_sort | high-throughput proteomics: a methodological mini-review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362039/ https://www.ncbi.nlm.nih.gov/pubmed/35922478 http://dx.doi.org/10.1038/s41374-022-00830-7 |
work_keys_str_mv | AT cuimiao highthroughputproteomicsamethodologicalminireview AT chengchao highthroughputproteomicsamethodologicalminireview AT zhanglanjing highthroughputproteomicsamethodologicalminireview |